Subcutaneous isatuximab via on-body delivery system matches IV efficacy with better experience in RRMM

Triple combination of venetoclax-ibrutinib-obinutuzumab prolongs PFS compared to venetoclax-CD20-antibodies

The combination of acimtamig and AlloNK therapy demonstrates promising efficacy in R/R cHL

Key insights from lung cancer research at ASCO 2025

POLA-R-GEMOX regimen is a promising option for relapsed/refractory diffuse large B-cell lymphoma

ASCO 2025: Importance of early testing in metastatic prostate cancer

Encorafenib/binimetinib/nivolumab combo improves PFS in BRAF-mutant melanoma brain metastases

Enhanced pathologic response with neoadjuvant pembrolizumab plus vidutolimod in high-risk resectable melanoma

Sacituzumab govitecan shows efficacy signals in muscle-invasive urothelial bladder cancer

HPK1 inhibitor NDI-101150 shows safety and antitumour activity in ccRCC

Catequentinib improves PFS vs placebo in advanced or metastatic leiomyosarcoma

Ropeginterferon Alfa-2b shows superior efficacy over anagrelide in essential thrombocythaemia